FDA Import Refusal AEK-4933137-2/21/1 — NOVO NORDISK EGYPT PHARMACEUTICA
The FDA refused shipment AEK-4933137-2/21/1 from NOVO NORDISK EGYPT PHARMACEUTICA (Egypt) on Apr 3, 2024. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Apr 3, 2024
- Country
- Egypt
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75